NV MPJE key terms

The state agency that licenses pharmacies and pharmacy personnel, adopts administrative rules, inspects practice sites, and disciplines licensees under the North Dakota Pharmacy Practice Act. It also registers controlled substance dispensing sites and approves continuing education.

North Dakota's statute governing pharmacy practice, defining licensure, scope of practice, and Board authority. Board rules adopted under it supply operational detail, and violations can support license discipline or criminal penalties.

The licensed pharmacist designated to a pharmacy who is accountable for legal compliance, recordkeeping, security of controlled substances, and overall operation of that licensed site. The Board must be notified when this person changes.

Board-issued authorization for a physical location to dispense, compound, or distribute drugs. It is site-specific and must be renewed, and changes of ownership, location, or manager generally require Board notification or a new application.

North Dakota authorization for a pharmacy located outside the state to ship prescription drugs to patients in North Dakota. The pharmacy must be licensed in its home state and comply with North Dakota labeling, counseling, and inspection requirements.

Board-issued credential allowing a person to practice pharmacy in North Dakota, obtained through approved education, examination, and internship requirements. Practice without a valid license is unlawful and subject to injunction and penalties.

Board-issued status allowing a pharmacy student to obtain practical experience under a preceptor's supervision. The intern may perform pharmacist duties only under required supervision, and hours must be documented for licensure eligibility.

A licensed pharmacist approved by the Board to supervise and evaluate pharmacy interns or students during experiential training. The preceptor verifies completed hours and remains responsible for the trainee's activities.

Board credential permitting a person to assist in pharmacy practice under pharmacist supervision. Technicians cannot perform duties reserved to pharmacists, such as final verification of prescriptions or patient counseling.

Mandatory ongoing education pharmacists must complete each renewal cycle, including Board-specified topics such as law and patient safety. Hours must be documented and retained for audit, and noncompliance can block license renewal.

Behavior by a licensee that violates practice standards or undermines public trust, such as practicing impaired, falsifying records, or dispensing without required authorization. It is a basis for Board discipline separate from criminal prosecution.

A confidential monitoring pathway for licensees with substance use or mental health conditions affecting practice, offering evaluation, treatment referral, and supervised return to work instead of or alongside discipline. Participation is typically coordinated by the Board.

The duty of pharmacists and employers to notify the Board of certain events, such as license discipline elsewhere, theft of controlled substances, or a licensee practicing while impaired. Failure to report can itself lead to discipline.

The pharmacist's obligation to offer meaningful information about a prescription, including directions, precautions, and interactions, before dispensing. It must be offered in person or by accessible alternative for mailed prescriptions and documented when refused.

Required information affixed to a dispensed container, including pharmacy identity, prescription number, patient name, drug name and strength, directions, quantity, prescriber, and date. Missing or incorrect labels are a common inspection finding.

The documentation a pharmacy must keep for each dispensing, including the original prescription, refill history, pharmacist identity, and dates. Records must be retrievable, retained for the required period, and available to inspectors.

A prospective and retrospective review of a prescription for therapeutic appropriateness, duplication, interactions, and dosing before dispensing. The pharmacist resolves identified problems with the prescriber or documents the intervention.

Preparing a customized drug product from ingredients or by manipulating a manufactured product for a specific patient's need. It requires documented formulas, beyond-use dates, and quality controls, and sterile compounding adds facility and testing standards.

A drug regulated under federal and state schedules because of abuse or dependence potential. Dispensing requires valid registration, proper prescribing authority, security, and recordkeeping, with stricter rules for Schedule II substances.

Federal authorization allowing a practitioner or pharmacy to handle controlled substances. It is separate from a state license, and a practitioner generally needs both a state license and a DEA number valid at the practice address.

A prescription for a highly restricted controlled substance that generally cannot be refilled and requires a written or qualifying electronic prescription. Emergency oral orders require a written follow-up within the federal time limit.

A count of all controlled substances on hand, taken at registration, on a change of ownership or location, and at required intervals. Records must be accurate, dated, and retained, and discrepancies trigger investigation and reporting.

An ongoing running record of controlled substance receipts, dispensings, and returns used to detect losses between physical counts. It supports reconciliation and helps identify diversion or recordkeeping errors promptly.

The obligation to notify DEA and the state Board when controlled substances are discovered missing or diverted. A DEA Form 106 documents significant losses, and prompt reporting is required to avoid further liability.

A state database recording dispensed controlled substances, which pharmacists must query under specified circumstances and report to promptly. It helps identify overlapping prescriptions, high-risk combinations, and possible misuse.

Permission from a prescriber to dispense additional quantities of a prescription beyond the original fill. Limits depend on the drug schedule, the prescriber's instructions, and the expiration date of the original prescription.

Moving prescription information between pharmacies so a patient can obtain refills elsewhere. Federal rules allow a one-time transfer of Schedule III-V prescriptions, and both pharmacies must retain transfer records.

A written arrangement between a pharmacist and prescriber authorizing the pharmacist to manage drug therapy, adjust doses, or initiate therapy under agreed protocols. It must meet statutory requirements and be documented and reviewed.

Legal power to initiate or modify drug therapy, which pharmacists hold only through specific statutory mechanisms such as collaborative agreements or defined protocols. It is narrower than dispensing authority.

Authorization for pharmacists to administer vaccines to specified age groups under state law, with training, certification, and reporting requirements. Documentation and emergency protocols must be maintained at the practice site.

The process for documenting and analyzing medication errors or near misses to prevent recurrence. Quality improvement records may receive confidentiality protection, and serious errors can require disclosure to the patient and Board.

The combined practices, technology, and workflow design a pharmacy uses to prevent errors, such as barcode verification, independent double checks, and clear labeling. The pharmacist-in-charge ensures these controls are in place and followed.

Rules governing whether dispensed drugs may be returned to inventory or must be destroyed. Controlled substances generally cannot be returned to stock after leaving the pharmacy, and reverse distributors handle disposal.

The required process when a pharmacy stops operating, including Board notification, transfer of prescription records, and surrender or secure storage of controlled substances. Patients must be able to obtain their records and remaining prescriptions.

The Board's power to enter and examine a pharmacy, its records, and its drug stock without prior notice. Inspections verify compliance and findings can lead to corrective orders, fines, or license action.

The process by which a pharmacist licensed in another jurisdiction obtains North Dakota licensure, typically through license verification and meeting current state requirements. The Board determines eligibility and may require additional examination.

The duty to protect prescription and health information from unauthorized disclosure, consistent with federal privacy rules and state law. Disclosures generally require patient authorization or a specific legal exception.